Global Transplant Solutions
PrivateLast Round
VC Round
Dec 6, 2018
Total Funding Raised
$92,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Global Transplant Solutions operates in Healthcare & Life Sciences and is based in Spartanburg, South Carolina. Its latest recorded funding round was a VC Round in December 2018.
Global Transplant Solutions is a medical supplies company that provides preservation solutions used in the human organ procurement and transplant market.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Global Transplant Solutions Comparables
Compare Global Transplant Solutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vascular Perfusion Solutions | 82% | |
| Terumo Corporation | 81% | |
| Getinge AB | 81% |
For institutional investors. Book with your work email.
Global Transplant Solutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 6, 2018 | ||||
| VC Round | Apr 12, 2018 | ||||
| Grant | Apr 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Global Transplant Solutions Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 185% MoM.
- Mar 1, 2026
Monthly visitors increased 61% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 7, 2026
Global Transplant Solutions, Inc. partners with S.A.L.F. S.p.A., a sterile-solution manufacturer based in Italy, to enhance the usability, storage, quality, and delivery of every organ-preservation solution produced.
- expands_offices_toOct 7, 2026
Global Transplant Solutions, Inc. begins operations in South Carolina in 2017 with a few employees at the Spark Center.
For institutional investors. Book with your work email.
Global Transplant Solutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Global Transplant Solutions's valuation, stock price, and market status.
Is Global Transplant Solutions a public or private company?
Global Transplant Solutions is a private company.
What is the current stock price of Global Transplant Solutions?
Global Transplant Solutions is a private company, so its shares have no public market price. Caplight tracks Global Transplant Solutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Global Transplant Solutions worth (valuation)?
Valuation information for Global Transplant Solutions is not publicly available.
Can I buy Global Transplant Solutions stock?
Global Transplant Solutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Global Transplant Solutions's last funding round?
Global Transplant Solutions's most recent funding round was VC Round on December 6, 2018.
Who are the main investors in Global Transplant Solutions?
Key investors in Global Transplant Solutions include SC Launch, SCRA.
Will Global Transplant Solutions IPO soon?
No public IPO plans have been announced for Global Transplant Solutions.
How can I track Global Transplant Solutions secondary market activity?
Caplight tracks bids, offers, and trades in Global Transplant Solutions's shares on secondary markets.